Press Releases-SINOVAC: Supply Vaccines to Eliminate Human Diseases-page1

Company
Innovation
Products

News
Investors
Careers
- Our Talent
中文 EN
Contact Us

Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

联系我们

当前地点：

EN

选择地点：

中文
EN

Home
Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

中文
EN

Press Releases

ALL YEAR

All
YEAR 2024
YEAR 2023
YEAR 2022
YEAR 2021
YEAR 2020
YEAR 2019
YEAR 2018
YEAR 2017
YEAR 2016
YEAR 2015
YEAR 2014
YEAR 2013
YEAR 2012
YEAR 2011
YEAR 2010
YEAR 2009
YEAR 2008
YEAR 2007
YEAR 2006
YEAR 2005

2007/12/26

Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
2007/12/14

Sinovac Requests Extension for Annual Shareholders Meeting
2007/12/14

Sinovac's Hepatitis A Vaccine Healive Selected by Beijing Centers For Diseases Control and Prevention
2007/12/12

Sinovac Reports Third Quarter 2007 Unaudited Financial Results
2007/11/21

Sinovac Files Form 6-K with SEC
2007/11/21

Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
2007/11/05

Sinovac Enters Purchase Agreement with Beijing Public Health Bureau for Anflu, Sinovac's Seasonal Influenza Vaccine
2007/09/21

Sinovac to Present at 2007 UBS Global Life Sciences Conference
2007/09/21

Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
2007/09/21

Sinovac Announces Postponement of Annual General Meeting
2007/08/16

Sinovac Reports First Half 2007 Financial Results
2007/08/15

Sinovac Commences Vaccination of Volunteers for the Clinical Research of Pandemic Influenza Vaccine (H5N1)
2007/08/14

Sinovac Schedules First Half 2007 Financial Results Date
2007/08/02

Sinovac Enters Exclusive Promotion Service Agreement with GlaxoSmithKline (China) Investment Co., Ltd.
2007/08/01

Sinovac Schedules Annual General Meeting
2007/07/30

Sinovac Receives Full Payment for Heping Wang's Obligations
2007/07/30

Sinovac Issues Corporate Update
2007/05/10

Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1)
2007/05/10

Sinovac to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals Conference
2007/05/10

Sinovac Reports 2006 Financial Results

Previous page1 2 Next page Go to No.

Follow Us

© SINOVAC All rights reserved